About EnClear Therapies
EnClear Therapies is a private company based in Cambridge, Massachusetts. It has reported $718,331 raised in one offering on Form D since March 2024. Its chief executive is Anthony DePasqua.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 22, 2024 | Mar 1, 2024 | $718,331of $1.9M target | 8 | $89,791 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EnClear Therapies's Form D filed Mar 1, 2024.
Jonathan Fleming
Director
Also an executive officer and director at Aquacultural Research, a director at Diceros Therapeutics and a board of directors at Quiver Bioscience.
JC
Jason Camm
Director
KR
Kasper Roet
Director
AD
Anthony DePasqua
Chief Executive Officer and director